Fatty-acid-based antimiR-23b allows brain delivery and reverses DM1 CNS defects in DMSXL mice

Myotonic dystrophy type 1 (DM1) is a multisystemic disorder caused by the expansion of CTG repeats in the 3′ untranslated region of DMPK. Although skeletal muscle and cardiac manifestations are among the most recognized features of the disease, DM1 also affects the central nervous system (CNS) and impacts significantly patients’ quality of life, with manifestations ranging from cognitive and behavioral abnormalities to sleep disturbances and, in the congenital form of the disease (CDM), severe neurodevelopmental impairment.

Authors

Institutions

Publication Details

Journal
Molecular Therapy — Nucleic Acids
Published
2026-11-13
DOI
https://doi.org/10.1016/j.omtn.2026.103166
Primary Topic
RNA Interference and Gene Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Fatty-acid-based antimiR-23b allows brain delivery and reverses DM1 CNS defects in DMSXL mice

Beatriz Llamusí, Geneviève Gourdon, Estefanía Cerro-Herreros, Ruben D. Artero et al.
2 links
Molecular Therapy — Nucleic Acids
RNA Interference and Gene Delivery
article

Fatty-acid-based antimiR-23b allows brain delivery and reverses DM1 CNS defects in DMSXL mice

Beatriz Llamusí, Geneviève Gourdon, Estefanía Cerro-Herreros, Ruben D. Artero, Diego Piqueras‐Losilla
article en

Abstract

Myotonic dystrophy type 1 (DM1) is a multisystemic disorder caused by the expansion of CTG repeats in the 3′ untranslated region of DMPK. Although skeletal muscle and cardiac manifestations are among the most recognized features of the disease, DM1 also affects the central nervous system (CNS) and impacts significantly patients’ quality of life, with manifestations ranging from cognitive and behavioral abnormalities to sleep disturbances and, in the congenital form of the disease (CDM), severe neurodevelopmental impairment.

Molecular Therapy — Nucleic AcidsVol. 37(4)
Inserm (FR), Universitat de València (ES), Instituto de Salud Carlos III (ES), Sorbonne Université (FR), Centre for Biomedical Network Research on Rare Diseases (ES), INCLIVA Health Research Institute (ES), Centre de Recherche en Myologie (FR), Menéndez Pelayo International University (ES)
Good health and well-being
RNA Interference and Gene Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon